UB Paderborn / Katalog / Suche / in CDI

Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics

CPT: pharmacometrics and systems pharmacology, 2017-02, Vol.6 (2), p.87-109

2017

Volltextzugriff (PDF)

Phase III Double-Blind Placebo-Controlled Study of Farnesyl Transferase Inhibitor R115777 in Patients With Refractory Advanced Colorectal Cancer

Journal of clinical oncology, 2004-10, Vol.22 (19), p.3950-3957

2004

Volltextzugriff (PDF)

Relationship between apalutamide (APA) exposure and metastasis-free survival (MFS) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC) from SPARTAN

Annals of oncology, 2018-10, Vol.29, p.viii278-viii278

2018

Volltextzugriff (PDF)

Phase III Trial of Gemcitabine Plus Tipifarnib Compared With Gemcitabine Plus Placebo in Advanced Pancreatic Cancer

Journal of clinical oncology, 2004-04, Vol.22 (8), p.1430-1438

2004

Volltextzugriff (PDF)

Mechanism-based Pharmacokinetic Pharmacodynamic Meta-analysis of Trabectedin (ET-743, Yondelis) Induced Neutropenia

Clinical pharmacology and therapeutics, 2008-01, Vol.83 (1), p.130-143

2008

Volltextzugriff (PDF)

SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques

Nature communications, 2021-10, Vol.12 (1), p.5877-5877, Article 5877

2021

Volltextzugriff (PDF)

Population Pharmacokinetics and Pharmacodynamics of the Calcimimetic Etelcalcetide in Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis

CPT: pharmacometrics and systems pharmacology, 2016-09, Vol.5 (9), p.484-494

2016

Volltextzugriff (PDF)

Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV

Journal of antimicrobial chemotherapy, 2021-11, Vol.76 (12), p.3255-3262

2021

Volltextzugriff (PDF)

Modelling intestinal absorption of salbutamol sulphate in rats

International journal of pharmaceutics, 2006-05, Vol.314 (1), p.21-30

2006

Volltextzugriff (PDF)

Development and validation of an HPLC-UV method for pazopanib quantification in human plasma and application to patients with cancer in routine clinical practice

Therapeutic drug monitoring, 2015-04, Vol.37 (2), p.172

2015

Volltextzugriff (PDF)

Phase II and Pharmacodynamic Study of the Farnesyltransferase Inhibitor R115777 as Initial Therapy in Patients With Metastatic Pancreatic Adenocarcinoma

Journal of clinical oncology, 2003-04, Vol.21 (7), p.1301-1306

2003

Volltextzugriff (PDF)

A translational model-based approach to inform the choice of the dose in phase 1 oncology trials: the case study of erdafitinib

Cancer chemotherapy and pharmacology, 2022, Vol.89 (1), p.117-128

2022

Volltextzugriff (PDF)

Romiplostim Dose Response in Patients With Immune Thrombocytopenia

Journal of clinical pharmacology, 2012-10, Vol.52 (10), p.1540-1551

2012

Volltextzugriff (PDF)

Cyclosporine concentration prediction using clustering and support vector regression methods

Electronics letters, 2002-06, Vol.38 (12), p.568-570

2002

Volltextzugriff (PDF)

Influencia de los polimorfismos genéticos en UGT1A1, UGT1A7 y UGT1A9 sobre la farmacocinética de irinotecán, SN-38 y SN-38G

Farmacia Hospitalaria, 2013-04, Vol.37 (2), p.111-127

2013

Volltextzugriff (PDF)

Population cell life span models for effects of drugs following indirect mechanisms of action

Journal of pharmacokinetics and pharmacodynamics, 2005-12, Vol.32 (5-6), p.767-793

2005

Volltextzugriff (PDF)

A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy

Breast cancer research and treatment, 2008-07, Vol.110 (2), p.327-335

2008

Volltextzugriff (PDF)

Clinical Implications of Complex Pharmacokinetics for Daratumumab Dose Regimen in Patients With Relapsed/Refractory Multiple Myeloma

Clinical pharmacology and therapeutics, 2017-06, Vol.101 (6), p.721-724

2017

Volltextzugriff (PDF)

Use of neural networks for dosage individualisation of erythropoietin in patients with secondary anemia to chronic renal failure

Computers in biology and medicine, 2003-07, Vol.33 (4), p.361-373

2003

Volltextzugriff (PDF)

Population pharmacokinetics of 5-fluorouracil in colorectal cancer patients

Journal of oncology pharmacy practice, 2004-09, Vol.10 (3), p.155-167

2004

Volltextzugriff (PDF)

Dosage individualization of erythropoietin using a profile-dependent support vector regression

IEEE transactions on biomedical engineering, 2003-10, Vol.50 (10), p.1136-1142

2003

Volltextzugriff (PDF)

Control gravimétrico en la nutrición parenteral Weight monitoring in parenteral nutritional

Nutrición hospitalaria : organo oficial de la Sociedad Española de Nutrición Parenteral y Enteral, 2003-08, Vol.18 (4), p.215-221

2003

Volltextzugriff (PDF)

Prediction of cyclosporine dosage in patients after kidney transplantation using neural networks

IEEE transactions on biomedical engineering, 2003-04, Vol.50 (4), p.442-448

2003

Volltextzugriff (PDF)

Cyclosporine concentration prediction using clustering and support vector regression methods

Electronics letters, 2002-06, Vol.38 (12), p.1-1

2002

Volltextzugriff (PDF)

Exposure-Response Modeling of Darbepoetin Alfa in Anemic Patients With Chronic Kidney Disease Not Receiving Dialysis

Journal of clinical pharmacology, 2010-09, Vol.50 (S9), p.75S-90S

2010

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics

Phase III Double-Blind Placebo-Controlled Study of Farnesyl Transferase Inhibitor R115777 in Patients With Refractory Advanced Colorectal Cancer

Relationship between apalutamide (APA) exposure and metastasis-free survival (MFS) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC) from SPARTAN

Phase III Trial of Gemcitabine Plus Tipifarnib Compared With Gemcitabine Plus Placebo in Advanced Pancreatic Cancer

Mechanism-based Pharmacokinetic Pharmacodynamic Meta-analysis of Trabectedin (ET-743, Yondelis) Induced Neutropenia

SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques

Population Pharmacokinetics and Pharmacodynamics of the Calcimimetic Etelcalcetide in Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis

Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV

Modelling intestinal absorption of salbutamol sulphate in rats

Development and validation of an HPLC-UV method for pazopanib quantification in human plasma and application to patients with cancer in routine clinical practice

Phase II and Pharmacodynamic Study of the Farnesyltransferase Inhibitor R115777 as Initial Therapy in Patients With Metastatic Pancreatic Adenocarcinoma

A translational model-based approach to inform the choice of the dose in phase 1 oncology trials: the case study of erdafitinib

Romiplostim Dose Response in Patients With Immune Thrombocytopenia

Cyclosporine concentration prediction using clustering and support vector regression methods

Influencia de los polimorfismos genéticos en UGT1A1, UGT1A7 y UGT1A9 sobre la farmacocinética de irinotecán, SN-38 y SN-38G

Population cell life span models for effects of drugs following indirect mechanisms of action

A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy

Clinical Implications of Complex Pharmacokinetics for Daratumumab Dose Regimen in Patients With Relapsed/Refractory Multiple Myeloma

Use of neural networks for dosage individualisation of erythropoietin in patients with secondary anemia to chronic renal failure

Population pharmacokinetics of 5-fluorouracil in colorectal cancer patients

Dosage individualization of erythropoietin using a profile-dependent support vector regression

Control gravimétrico en la nutrición parenteral Weight monitoring in parenteral nutritional

Prediction of cyclosporine dosage in patients after kidney transplantation using neural networks

Cyclosporine concentration prediction using clustering and support vector regression methods

Exposure-Response Modeling of Darbepoetin Alfa in Anemic Patients With Chronic Kidney Disease Not Receiving Dialysis

Suchergebnisse filtern